{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:53:18Z","timestamp":1776837198268,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s10072-015-2133-1","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T16:31:53Z","timestamp":1432657913000},"page":"109-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Emerging treatments for the primary headache disorders"],"prefix":"10.1007","volume":"36","author":[{"given":"Nathaniel M.","family":"Schuster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Vollbracht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan M.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"2133_CR1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/head.12179","volume":"53","author":"ME Bigal","year":"2013","unstructured":"Bigal ME, Walter S, Rapoport AM (2013) Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache 53:1230\u20131244","journal-title":"Headache"},{"key":"2133_CR2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.0000000000000771","volume":"83","author":"TW Ho","year":"2014","unstructured":"Ho TW, Connor KM, Zhang Y et al (2014) Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Neurology 83:958\u2013966","journal-title":"Neurology"},{"key":"2133_CR3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","volume":"13","author":"D Dodick","year":"2014","unstructured":"Dodick D, Goadsby P, Spierings E et al (2014) Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol 13:885\u2013892","journal-title":"Lancet Neurol"},{"key":"2133_CR4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","volume":"13","author":"D Dodick","year":"2014","unstructured":"Dodick D, Goadsby P, Silberstein S et al (2014) Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol 13:1100\u20131107","journal-title":"Lancet Neurol"},{"key":"2133_CR5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(01)06347-4","volume":"358","author":"DJ Goldstein","year":"2001","unstructured":"Goldstein DJ, Roon KI, Offen WW et al (2001) Selective serotonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet 358:1230\u20131234","journal-title":"Lancet"},{"key":"2133_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(12)70047-9","volume":"11","author":"M Farkkila","year":"2012","unstructured":"Farkkila M, Diener HC, Geraud G et al (2012) Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol 11:405\u2013413","journal-title":"Lancet Neurol"},{"key":"2133_CR7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/0333102412473667","volume":"33","author":"J Schoenen","year":"2013","unstructured":"Schoenen J, Jensen RH, Lanteri-Minet M et al (2013) Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia 33:816\u2013830","journal-title":"Cephalalgia"},{"key":"2133_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0b013e3182825055","volume":"80","author":"J Schoenen","year":"2013","unstructured":"Schoenen J, Vandersmissen B, Jeangette S et al (2013) Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology 80:697\u2013704","journal-title":"Neurology"},{"key":"2133_CR9","doi-asserted-by":"crossref","unstructured":"Gaul C, Diener H, Solbach K (2014) Non-invasive vagus nerve stimulation Using gammaCore for the prevention and acute treatment of chronic cluster headache: report from the randomised phase of the PREVA Study. In: 4th European Headache and Migraine Trust International Congress. Copenhagen, Denmark","DOI":"10.1186\/1129-2377-15-S1-I7"},{"key":"2133_CR10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0333102414524494","volume":"34","author":"PJ Goadsby","year":"2014","unstructured":"Goadsby PJ, Grosberg BM, Mauskop A et al (2014) Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia 34:986\u2013993","journal-title":"Cephalalgia"},{"key":"2133_CR11","unstructured":"Silberstein SD, Da Silva AN, Calhoun AH et al (2014) Non-invasive vagus nerve stimulation for chronic migraine prevention in a prospective, randomized, sham-controlled pilot study (the EVENT study): report from the double-blind phase. 56th Annual Scientific Meeting of the American Headache Society, Los Angeles"},{"key":"2133_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09066-5_1","volume":"42","author":"D Fontaine","year":"2015","unstructured":"Fontaine D, Vandersteen C, Magis D et al (2015) Adv Tech Stand Neurosurg 42:3\u201321","journal-title":"Adv Tech Stand Neurosurg"},{"key":"2133_CR13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0333102410381142","volume":"31","author":"JR Saper","year":"2011","unstructured":"Saper JR, Dodick DW, Silberstein SD et al (2011) Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 31:271\u2013285","journal-title":"Cephalalgia"},{"key":"2133_CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","volume":"9","author":"RB Lipton","year":"2010","unstructured":"Lipton RB, Dodick DW, Silberstein SD et al (2010) Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 9:373\u2013380","journal-title":"Lancet Neurol"},{"key":"2133_CR15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1526-4610.2012.02198.x","volume":"52","author":"J Goldstein","year":"2012","unstructured":"Goldstein J, Smith T, Pugach N et al (2012) A sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Headache 52:1402\u20131410","journal-title":"Headache"},{"key":"2133_CR16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1526-4610.2011.01869.x","volume":"51","author":"S Aurora","year":"2011","unstructured":"Aurora S, Silberstein S, Kori S et al (2011) MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache 51:507\u2013517","journal-title":"Headache"},{"key":"2133_CR17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/head.12472","volume":"55","author":"R Cady","year":"2015","unstructured":"Cady R, McAllister P, Spierings E et al (2015) A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (the TARGET study). Headache 55:88\u2013100","journal-title":"Headache"},{"issue":"Suppl 1","key":"2133_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10072-014-1747-z","volume":"35","author":"S Vollbracht","year":"2014","unstructured":"Vollbracht S, Rapoport AM (2014) New treatments for headache. Neurol Sci 35(Suppl 1):89\u201397","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-015-2133-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-015-2133-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-015-2133-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T12:02:38Z","timestamp":1566734558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-015-2133-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":18,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1007\/s10072-015-2133-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}